Veradermics reports Q3 2026 results, $798.4 million cash, runway into 2030Nov 10Clinical readoutAbsci CorpVDPHL01Updated
Pfizer raises 2026 guidance after Q3, reports pipeline progress and new CFONov 3Quarterly updateBioNTech SEC4 Therapeutics, Inc.
Veradermics reports positive Phase 3 topline data for oral minoxidil in male hair lossOct 19Clinical readoutminoxidilVDPHL01
Veradermics reports Q2 2026 results, completes enrollment in female pattern hair loss trialAug 11Quarterly updateVeradermics, Inc.
Veradermics reports positive Phase 2 data for oral VDPHL01 in female hair lossJul 15Clinical readoutVDPHL01Veradermics, Inc.